CN106176350A - Bath gel with effect of weight reducing and preparation method thereof - Google Patents
Bath gel with effect of weight reducing and preparation method thereof Download PDFInfo
- Publication number
- CN106176350A CN106176350A CN201610573423.1A CN201610573423A CN106176350A CN 106176350 A CN106176350 A CN 106176350A CN 201610573423 A CN201610573423 A CN 201610573423A CN 106176350 A CN106176350 A CN 106176350A
- Authority
- CN
- China
- Prior art keywords
- parts
- extracts
- bath gel
- extract
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000000694 effects Effects 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 239000000284 extract Substances 0.000 claims abstract description 101
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid group Chemical class C(CC(O)(C(=O)O)CC(=O)O)(=O)O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000002994 raw material Substances 0.000 claims abstract description 26
- 235000015165 citric acid Nutrition 0.000 claims abstract description 18
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 17
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 17
- 239000001102 lavandula vera Substances 0.000 claims abstract description 16
- 235000018219 lavender Nutrition 0.000 claims abstract description 16
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 33
- 239000000203 mixture Substances 0.000 claims description 20
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 claims description 15
- 244000269722 Thea sinensis Species 0.000 claims description 15
- 229960003330 pentetic acid Drugs 0.000 claims description 13
- 244000060011 Cocos nucifera Species 0.000 claims description 11
- 235000013162 Cocos nucifera Nutrition 0.000 claims description 11
- 239000000049 pigment Substances 0.000 claims description 9
- 239000004094 surface-active agent Substances 0.000 claims description 9
- HMEKVHWROSNWPD-UHFFFAOYSA-N Erioglaucine A Chemical compound [NH4+].[NH4+].C=1C=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C(=CC=CC=2)S([O-])(=O)=O)C=CC=1N(CC)CC1=CC=CC(S([O-])(=O)=O)=C1 HMEKVHWROSNWPD-UHFFFAOYSA-N 0.000 claims description 8
- 244000299461 Theobroma cacao Species 0.000 claims description 8
- 235000009470 Theobroma cacao Nutrition 0.000 claims description 8
- 229940057950 sodium laureth sulfate Drugs 0.000 claims description 8
- SXHLENDCVBIJFO-UHFFFAOYSA-M sodium;2-[2-(2-dodecoxyethoxy)ethoxy]ethyl sulfate Chemical group [Na+].CCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O SXHLENDCVBIJFO-UHFFFAOYSA-M 0.000 claims description 8
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 7
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 7
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 7
- 239000003755 preservative agent Substances 0.000 claims description 7
- 230000002335 preservative effect Effects 0.000 claims description 7
- 239000003974 emollient agent Substances 0.000 claims description 6
- 235000009569 green tea Nutrition 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 4
- 235000020688 green tea extract Nutrition 0.000 abstract description 12
- 229940094952 green tea extract Drugs 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 241000411851 herbal medicine Species 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 14
- 150000008442 polyphenolic compounds Chemical class 0.000 description 12
- 235000013824 polyphenols Nutrition 0.000 description 12
- 235000002639 sodium chloride Nutrition 0.000 description 12
- -1 triterpenes agate Saponin Chemical class 0.000 description 12
- 235000013616 tea Nutrition 0.000 description 11
- 210000004369 blood Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 10
- 235000019197 fats Nutrition 0.000 description 10
- 238000000034 method Methods 0.000 description 9
- 230000008569 process Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- 229940119429 cocoa extract Drugs 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000001629 suppression Effects 0.000 description 5
- IPQVTOJGNYVQEO-UHFFFAOYSA-N 9-[2-carboxy-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracen-9-yl]-4-hydroxy-10-oxo-5-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-9h-anthracene-2-carboxylic acid Chemical group OC1C(O)C(O)C(CO)OC1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1C2C1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(OC3C(C(O)C(O)C(CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000219138 Luffa Species 0.000 description 4
- 235000003956 Luffa Nutrition 0.000 description 4
- 108010077895 Sarcosine Proteins 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000033228 biological regulation Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 150000002148 esters Chemical class 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 210000004165 myocardium Anatomy 0.000 description 4
- 238000007789 sealing Methods 0.000 description 4
- 229930186851 sennoside Natural products 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000005202 decontamination Methods 0.000 description 3
- 230000003588 decontaminative effect Effects 0.000 description 3
- 239000003792 electrolyte Substances 0.000 description 3
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 229940048098 sodium sarcosinate Drugs 0.000 description 3
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 2
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- CFLNHFUPWNRWJA-UHFFFAOYSA-N Obtusin Chemical compound O=C1C2=CC(C)=C(O)C(OC)=C2C(=O)C2=C1C=C(OC)C(OC)=C2O CFLNHFUPWNRWJA-UHFFFAOYSA-N 0.000 description 2
- OBBJQZSMXOJMCN-UHFFFAOYSA-N Obtusin Natural products COc1cc2C=CC(=O)Oc2c3OCC(Oc13)C(=C)C OBBJQZSMXOJMCN-UHFFFAOYSA-N 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- RJGDLRCDCYRQOQ-UHFFFAOYSA-N anthrone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3CC2=C1 RJGDLRCDCYRQOQ-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229960002173 citrulline Drugs 0.000 description 2
- 235000013477 citrulline Nutrition 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 125000005456 glyceride group Chemical group 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- CZVXBFUKBZRMKR-UHFFFAOYSA-N lavandulol Chemical compound CC(C)=CCC(CO)C(C)=C CZVXBFUKBZRMKR-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- UWKAYLJWKGQEPM-LBPRGKRZSA-N linalyl acetate Chemical compound CC(C)=CCC[C@](C)(C=C)OC(C)=O UWKAYLJWKGQEPM-LBPRGKRZSA-N 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 230000036284 oxygen consumption Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- WEHXAEGTVPWKDY-UHFFFAOYSA-N toralactone Chemical compound C1=C(C)OC(=O)C=2C1=CC1=CC(OC)=CC(O)=C1C=2O WEHXAEGTVPWKDY-UHFFFAOYSA-N 0.000 description 2
- 210000004881 tumor cell Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- NTWLPZMPTFQYQI-UHFFFAOYSA-N (3alpha)-olean-12-ene-3,23-diol Natural products C1CC(O)C(C)(CO)C2CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC3C21C NTWLPZMPTFQYQI-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CZVXBFUKBZRMKR-JTQLQIEISA-N (R)-lavandulol Natural products CC(C)=CC[C@@H](CO)C(C)=C CZVXBFUKBZRMKR-JTQLQIEISA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical compound O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- OTLLEIBWKHEHGU-UHFFFAOYSA-N 2-[5-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy]-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-4-phosphonooxyhexanedioic acid Chemical compound C1=NC=2C(N)=NC=NC=2N1C(C(C1O)O)OC1COC1C(CO)OC(OC(C(O)C(OP(O)(O)=O)C(O)C(O)=O)C(O)=O)C(O)C1O OTLLEIBWKHEHGU-UHFFFAOYSA-N 0.000 description 1
- FZIPCQLKPTZZIM-UHFFFAOYSA-N 2-oxidanylpropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O FZIPCQLKPTZZIM-UHFFFAOYSA-N 0.000 description 1
- WOTIUKDGJBXFLG-UHFFFAOYSA-N 3-methyl-1,2-thiazole Chemical compound CC=1C=CSN=1 WOTIUKDGJBXFLG-UHFFFAOYSA-N 0.000 description 1
- KFGWEMFTDGCYSK-UHFFFAOYSA-N 3-methyl-1,2-thiazole 1-oxide Chemical compound CC=1C=CS(=O)N=1 KFGWEMFTDGCYSK-UHFFFAOYSA-N 0.000 description 1
- ZOLBALGTFCCTJF-UHFFFAOYSA-N 4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;sulfuric acid Chemical compound OS(O)(=O)=O.CC(C)NCC(O)C1=CC=C(O)C(O)=C1.CC(C)NCC(O)C1=CC=C(O)C(O)=C1 ZOLBALGTFCCTJF-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 241000193155 Clostridium botulinum Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000010282 Emodin Substances 0.000 description 1
- CBOKHFLBNZMMAA-UHFFFAOYSA-N Emodin anthrone Natural products OC1=CC(O)=CC2=CC3=CC(C)=CC(O)=C3C(O)=C21 CBOKHFLBNZMMAA-UHFFFAOYSA-N 0.000 description 1
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229940123457 Free radical scavenger Drugs 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- GCGBHJLBFAPRDB-UHFFFAOYSA-N Hederagenin Natural products CC1(C)CCC2(CCC3(C)C4CCC5C(C)(CO)C(O)CCC5(C)C4CC=C3C2C1)C(=O)O GCGBHJLBFAPRDB-UHFFFAOYSA-N 0.000 description 1
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- YXVXMURDCBMPRH-UHFFFAOYSA-N Lirinidine Natural products C1C2=CC=CC=C2C2=C(O)C(OC)=CC3=C2C1N(C)CC3 YXVXMURDCBMPRH-UHFFFAOYSA-N 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- ORJVQPIHKOARKV-UHFFFAOYSA-N Nuciferine Natural products C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2C1N(C)CC3 ORJVQPIHKOARKV-UHFFFAOYSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010051246 Photodermatosis Diseases 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 1
- GCGBHJLBFAPRDB-KCVAUKQGSA-N Scutellaric acid Natural products CC1(C)CC[C@@]2(CC[C@@]3(C)[C@@H]4CC[C@H]5[C@@](C)(CO)[C@H](O)CC[C@]5(C)[C@H]4CC=C3[C@@H]2C1)C(=O)O GCGBHJLBFAPRDB-KCVAUKQGSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- SMWDFEZZVXVKRB-UHFFFAOYSA-N anhydrous quinoline Natural products N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N beta-hydroxyethanesulfonic acid Natural products OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AYFCVLSUPGCQKD-UHFFFAOYSA-L calcium;trisodium;2-[bis[2-[bis(carboxylatomethyl)azaniumyl]ethyl]azaniumyl]acetate Chemical compound [Na+].[Na+].[Na+].[Ca+2].[O-]C(=O)C[NH+](CC([O-])=O)CC[NH+](CC(=O)[O-])CC[NH+](CC([O-])=O)CC([O-])=O AYFCVLSUPGCQKD-UHFFFAOYSA-L 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229940025250 camphora Drugs 0.000 description 1
- 239000010238 camphora Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 230000000112 colonic effect Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000009837 dry grinding Methods 0.000 description 1
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical group C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 1
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 1
- LAJSXCAVRQXZIO-UHFFFAOYSA-N emodin anthrone Chemical compound C1=C(O)C=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O LAJSXCAVRQXZIO-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 231100000776 exotoxin Toxicity 0.000 description 1
- 239000002095 exotoxin Substances 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 201000005577 familial hyperlipidemia Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000003736 gastrointestinal content Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229930187479 gypenoside Natural products 0.000 description 1
- ZRBFCAALKKNCJG-UHFFFAOYSA-N gypenoside-XVII Natural products C1CC(C2(CCC3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C(O)C1O ZRBFCAALKKNCJG-UHFFFAOYSA-N 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- PGOYMURMZNDHNS-MYPRUECHSA-N hederagenin Chemical compound C1C[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C PGOYMURMZNDHNS-MYPRUECHSA-N 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229940045996 isethionic acid Drugs 0.000 description 1
- 229940018435 isoproterenol sulfate Drugs 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- UWKAYLJWKGQEPM-UHFFFAOYSA-N linalool acetate Natural products CC(C)=CCCC(C)(C=C)OC(C)=O UWKAYLJWKGQEPM-UHFFFAOYSA-N 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- ORJVQPIHKOARKV-OAHLLOKOSA-N nuciferine Chemical compound C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C2[C@@H]1N(C)CC3 ORJVQPIHKOARKV-OAHLLOKOSA-N 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940067082 pentetate Drugs 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000008845 photoaging Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 1
- OISYIJRGMYJBRH-UHFFFAOYSA-N physcione Natural products COc1cc(O)c2C(=O)c3ccc(O)cc3C(=O)c2c1 OISYIJRGMYJBRH-UHFFFAOYSA-N 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- HJSRRUNWOFLQRG-UHFFFAOYSA-N propanedioic acid Chemical compound OC(=O)CC(O)=O.OC(=O)CC(O)=O HJSRRUNWOFLQRG-UHFFFAOYSA-N 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- FPNKCZKRICBAKG-UHFFFAOYSA-N rubrofusarin Chemical compound O1C(C)=CC(=O)C=2C1=CC1=CC(OC)=CC(O)=C1C=2O FPNKCZKRICBAKG-UHFFFAOYSA-N 0.000 description 1
- KLKFLNXANXGSIT-UHFFFAOYSA-N rubrofusarin Natural products O1C(C)=CC(=O)C2=C1C=C1C=C(O)C=C(OC)C1=C2O KLKFLNXANXGSIT-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 229910001753 sapphirine Inorganic materials 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 235000011149 sulphuric acid Nutrition 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 208000012991 uterine carcinoma Diseases 0.000 description 1
- 230000003845 vascular endothelial function Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 229940075420 xanthine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
- A61K36/424—Gynostemma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K8/442—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof substituted by amido group(s)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses bath gel with effect of weight reducing and preparation method thereof.This bath gel comprises 5～10 parts of green tea extracts according to its raw material of mass parts, 5～10 parts of Fructus Crataegi extracts, 5～10 parts of Herb Gynostemmae Pentaphylli extracts, 5～10 parts of Folium Nelumbinis extracts, 5～10 parts of Folium Sennae extracts, 5～10 parts of Semen Cassiae extracts, 5～10 portions of Fructus Luffae extracts, 5～10 parts of citric acids, 5～10 parts of lavender flower extracts, and the bath gel of the bath gel component present invention, green tea extract is added in bath gel component, Fructus Crataegi extract, Herb Gynostemmae Pentaphylli extract, Folium Nelumbinis extract, Folium Sennae extract, Semen Cassiae extract, Fructus Luffae extract, citric acid, lavender flower extract, these Chinese herbal medicine extracts compound containing the more fat-reducing factor, thus ensure that the bath gel of the present invention has effect of preferable fat-reducing.
Description
Technical field
The present invention relates to the technical field of bath gel, in particular to bath gel and the preparation thereof with effect of weight reducing
Method.
Background technology
Bath gel of the prior art only has the effect of decontamination skin-protection, does not possess effect of fat-reducing.
Summary of the invention
In view of this, one aspect of the present invention is to provide a kind of bath gel with effect of weight reducing, and this bath gel has relatively
Good effect of weight reducing.
A kind of bath gel with effect of weight reducing, according to its raw material of mass parts comprise 5～10 parts of green tea extracts, 5～10
Part Fructus Crataegi extract, 5～10 parts of Herb Gynostemmae Pentaphylli extracts, 5～10 parts of Folium Nelumbinis extracts, 5～10 parts of Folium Sennae extracts, 5～10
Part Semen Cassiae extract, 5～10 parts of Fructus Luffae extracts, 5～10 parts of citric acids, 5～10 parts of lavender flower extracts, and take a shower
Dew component.
Further, 10～20 parts of surfactants, 10～20 parts of skin moistening are comprised according to bath gel component described in mass parts
Agent, 5～10 parts of viscosity-controlling agents, 10～20 parts of pigments, 10～20 portions of preservative, 5～10 parts of essence and 5～10 parts of solvents.
Further, described surfactant is sodium laureth sulfate and/or coconut oleoyl amine DEA.
Further, described emollient is glycerol and/or Palmic acid.
Further, described pigment is CI17200 and/or CI42090.
Further, described preservative is methylchloroisothiazandnone and/or Methylisothiazolinone.
Further, 5～10 portions of fresheners are also comprised according to bath gel component described in mass parts.
Further, 5～10 parts of pentetic acid are also comprised according to mass parts.
Further, 5～10 parts of cocoa extracts are also comprised according to mass parts.
Another aspect of the present invention is to provide the preparation method of a kind of such as above-mentioned bath gel, by washing one's hair that this preparation method obtains
Bath lotion has effect of preferable fat-reducing.
The preparation method of a kind of such as above-mentioned bath gel, obtained by each raw material mix homogeneously.
The bath gel of the present invention, in bath gel component add green tea extract, Fructus Crataegi extract, Herb Gynostemmae Pentaphylli extract,
Folium Nelumbinis extract, Folium Sennae extract, Semen Cassiae extract, Fructus Luffae extract, citric acid, lavender flower extract, in these
Herb extracts compounds, and containing the more fat-reducing factor, thus ensures that the bath gel of the present invention has effect of preferable fat-reducing.
Detailed description of the invention
For the ease of understanding the present invention, further illustrate technical scheme below in conjunction with embodiment.
As used herein, term:
" one ", " a kind of " and " described " are used interchangeably and refer to one or more.
"and/or" for represent the one or both of illustrated situation all it may happen that, such as, A and/or B includes (A
And B) and (A or B)；
It addition, all numerical value that the scope stated by end points herein is comprised in the range of including this (such as, 1 to 10 bag
Include 1.4,1.9,2.33,5.75,9.98 etc.).
It addition, the statement of " at least one " herein include one and above all numbers (such as, at least 2, at least
4, at least 6, at least 8, at least 10, at least 25, at least 50, at least 100 etc.).
The bath gel with effect of weight reducing of the present invention, according to its raw material of mass parts comprise 5～10 parts of green tea extracts, 5
～10 parts of Fructus Crataegi extracts, 5～10 parts of Herb Gynostemmae Pentaphylli extracts, 5～10 parts of Folium Nelumbinis extracts, 5～10 parts of Folium Sennae extracts, 5
～10 parts of Semen Cassiae extracts, 5～10 parts of Fructus Luffae extracts, 5～10 parts of citric acids, 5～10 parts of lavender flower extracts, and
Bath gel component.Such as, specifically, the mass parts of green tea extract can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8
Part, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts etc.；The mass parts of Fructus Crataegi extract can be 5 parts, 5.2 parts, 5.5 parts, 6 parts,
7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts etc.；The mass parts of Herb Gynostemmae Pentaphylli extract can be 5 parts, 5.2
Part, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts；The mass parts of Folium Nelumbinis extract is permissible
It is 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts；Folium Sennae extract
Mass parts can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts；
The mass parts of Semen Cassiae extract can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts,
9.9 parts or 10 parts；The mass parts of Fructus Luffae extract can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5
Part, 9.8 parts, 9.9 parts or 10 parts；The mass parts of citric acid can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9
Part, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts；The mass parts of lavender flower extract can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7
Part, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts.
Green tea extract refers to the active component extracted from green tea blade.Its caffeine contained be a kind of fat-reducing because of
Son.Additionally, it is possibly together with tea polyphenols, aromatic oil, moisture, mineral, pigment, carbohydrate, protein, aminoacid, dimension life
The nutrient substance such as element.Tea polyphenols is a kind of composition that green tea extract content is most, and it has some other health-care effect: 1,
Effect for reducing blood fat, i.e. its contained tea polyphenols can substantially reduce the serum total cholesterol of hyperlipemia, triglyceride, low-density
Lipoprotein cholesterol content, has simultaneously and recovers and the effect of protection vascular endothelial function.The effect for reducing blood fat of tea polyphenols is also
Folium Camelliae sinensis can make overweight people lose weight the one of the main reasons not rebounded.2, antioxidation, i.e. tea polyphenols can block lipid peroxidation
Process, improves the activity of human enzymes, thus plays effect of mutation, anticancer.3, function of tumor inhibition, i.e. tea polyphenols can
The synthesis of suppression DNA of tumor cell, lures that mutant DNA ruptures into, thus can suppress the synthetic ratio of tumor cell, suppression is swollen further
The propagation of the growth of tumor.4, disinfecting detoxifying, i.e. tea polyphenols can kill bacillus botulinus and spore, the activity of suppression bacterial exotoxin.
The various pathogen causing diarrhoea, respiratory tract and skin infection there is antibacterial action.Tea polyphenols is to causing pyogenic infection, burning
Wound, the staphylococcus aureus of wound, modification bacillus have obvious inhibitory action.5, relieve the effect of alcohol and the liver protecting, i.e. tea polyphenols are made
For free radical scavenger, there is the effect of suppression alcoholic liver injury.6, detoxicating effect, i.e. tea polyphenols heavy metal have strong
Adsorption, can form complex with heavy metal and produce precipitation, be conducive to alleviating the toxic action that human body is produced by heavy metal.
7, improving immunity of organisms, i.e. tea polyphenols by raising human immunoglobulin total amount and makes it maintain high level, stimulates anti-
The change of body activity, thus improve the overall immune ability of people.
Fructus Crataegi extract can have effect for reducing fat relatively certainly to hyperlipidemia models various in human body, short of money can do high lipid food and draw
The serum cholesterol risen and content of triglyceride raise, thus contribute to fat-reducing.Additionally, also have following health-care effect: 1 heart tonifying
Effect, can increase myocardial contraction, increases cardiac output, the effect of decreasing heart rate.2, to coronary flow and myocardial oxygen consumption
The effect of amount: Fructus Crataegi extract and total flavones thereof have increase coronary flow, reduces myocardial oxygen consumption and cardiac muscle coefficient of oxygen utilization
Effect.3, the regulation effect to cardiac muscle nutritional blood flow, i.e. Fructus Crataegi have certain increasing action to cardiac muscle nutritional blood flow,
Fructus Crataegi, may be with dilating coronary blood vessel bed, to improve coronary circulation relevant to cardiac muscle nutritional blood flow increasing action.4, to experiment
The protective effect of property myocardial ischemia, i.e. Fructus Crataegi has protective effect to by isoproterenol sulfate induced Acute myocardial ischemia.
5, hypotensive effect.
Herb Gynostemmae Pentaphylli extract is lost weight the factor as one, and its active component is gypenoside, belongs to tetracyclic triterpenes agate
Saponin, this active component CAS is 15588-68-8, and molecular formula is C80H126O44.Herb Gynostemmae Pentaphylli extract has following health care
Effect: 1, antitumaous effect, i.e. has inhibitory action to the propagation of the cancerous cell such as hepatocarcinoma, pulmonary carcinoma, uterus carcinoma and melanosarcoma；2, anti-
Old and feeble effect, can strengthen body immune function；3, effect for reducing blood fat；4, the side effect of glucocorticoid is prevented and treated.
Folium Nelumbinis extract is lost weight the factor as one.It is also known as nuciferine.It prepares substantially process, to shine dry grinding
Folium Nelumbinis is raw material, uses cellulase pretreatment, dilute hydrochloric acid extraction, ultrasonic assistant extraction, united extraction liquid, and PH is adjusted in alkalization
Value, concentration and evaporation water, to the extractum of proportion D=1.15, cools, and 10 times amount chloroforms stir, stand, are layered, and aqueous phase continues extraction three
Secondary, combined chloroform phase, reclaim chloroform, extractum dusts, and pulverizes, mixing.It is present that Folium Nelumbinis extract also has following health body: can profit
Urine relieving constipation, logical intestinal poison, blood fat reducing oil removing, clearing away summer-heat are antipyretic etc. acts on, and can substantially reduce triglyceride and cholesterol level in serum, can
Regulation blood fat.
Folium Sennae extract is lost weight the factor as one.The active component of Folium Sennae extract is Sennosides (i.e. Sennosides
A, A1, B, C, D, E, F, G), possibly together with a small amount of Anthraquinones, such as aloe-emodin and chrysophanic acid-8-glycoside；Viscose glue
Matter, such as tannic acid and flavonoid.Sennosides is converted to another kind of material, chrysophanic acid anthrone, this thing by microorganism in colon
Matter has useful effect to stimulate Colonic Activity (it accelerates enterokinesia and improves digestion) and increases fluid secretion.Sennosides light
The effect of rushing down and its active metabolite chrysophanic acid anthrone can suppress large intestine to water and the absorption of electrolyte, thus increase intestinal contents
Volume and pressure.It will stimulate the pusher striction sport of colon.It addition, the stimulation of active chloride secretion is added
Enteral water and the content of electrolyte.These changes in active electrolyte is transported depend on the calcium constituent on serosal surface.
The composition of Semen Cassiae extract is emodin monoglucoside, emodin anthrone, physcione, obtusin, orange
Obtusin, and rubrofusarin, Semen Cassiae pine, toralactone, still containing vitamin A.Its effect is mainly reflected in: 1,
Clearing away heat to improve acuity of vision, loosening bowel to relieve constipation.2, blood fat reducing improving eyesight, liver heat removing and eyesight improving, conjunctival congestion and swelling pain, keep in dark place many tear, habitual constipation.3, antibacterial, disappear
Scorching effect, effective to dental ulcer treatment.4, headache and dizzy, hypertension, hyperlipidemia, high-cholesterol disease.5, tremulous pulse is alleviated hard
Change, anti-angiocardiopathy, improve immunity.
The active component of Fructus Luffae extract is triterpene saponin component, i.e. Fructus Luffae glycoside (lycyoside) A, F, J, K, L, M, (3-
O-β-D-hlucopyranosyl hederagenin), 3-O-β-D-glucopyranosyl oleanolic acid (3-O-β-D-
Glucopyranosyloleanolic acid), also containing malonic acid (malonic acid), citric acid (citric acid) etc.
Fatty acid, citrulline (citrulline) etc..It has heat clearing away, reduce phlegm, removing heat from blood, effect of removing toxic substances.
Citric acid has the strongest contractility, is thus advantageous to reduce fat, is a kind of fat-reducing factor.Additionally, it also has
There is following effect: citric acid has the effect preventing and eliminating cutaneous pigmentation.2, expectorant.Additionally, citric acid is physiology
Middle fat, protein and sugar are converted into the important compound during carbon dioxide, provide energy for higher organism.
Lavender flower extract is lost weight the factor as one, its main component linalool, linalyl acetate, eucalyptole, B-
Luo Qin alkene is to (including cis and trans), acetic acid lavandula angustifolia ester, lavandulol, terpene-4-alcohol and Camphora etc..Additionally, it also has
Following health-care effect: 1, refreshment, hypermnesis；2, alleviate nerve, contribute to one's peace of mind of inner tranquility, there is dormifacient magical merit of calming the nerves
Effect.3, blood circulation promoting, can treat comedo, nourishes healthy hair；4, suppression hypertension.5, enhancing immunity.6, breathing is maintained
Road function.7, can preventing viral, infectious disease.
Bath gel component refers to play deoils to skin decontamination and the composition of effect of the conventional bath gel such as skin protection.Can enumerate
Go out the particular make-up of the composition of a kind of bath gel, such as according to mass parts its can comprise 10～20 parts of surfactants, 10～20
Part emollient, 5～10 parts of viscosity-controlling agents, 10～20 parts of pigments, 10～20 portions of preservative, 5～10 parts of essence and 5～10 parts are molten
Agent.Specifically, the mass parts of surfactant can be 10 parts, 10.2 parts, 10.5 parts, 11 parts, 12 parts, 14 parts, 15 parts, 17
Part, 18 parts, 19 parts, 19.5 parts, 19.8 parts or 20 parts etc.；The mass parts of emollient can be 10 parts, 10.2 parts, 10.5 parts, 11
Part, 12 parts, 14 parts, 15 parts, 17 parts, 18 parts, 19 parts, 19.5 parts, 19.8 parts or 20 parts；The mass parts of viscosity-controlling agent can be
5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts；The mass parts of pigment can
Think 10 parts, 10.2 parts, 10.5 parts, 11 parts, 12 parts, 14 parts, 15 parts, 17 parts, 18 parts, 19 parts, 19.5 parts, 19.8 parts or 20
Part；The mass parts of preservative can be 10 parts, 10.2 parts, 10.5 parts, 11 parts, 12 parts, 14 parts, 15 parts, 17 parts, 18 parts, 19 parts,
19.5 parts, 19.8 parts or 20 parts；The mass parts of essence can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts,
9.5 parts, 9.8 parts, 9.9 parts or 10 parts；The mass parts of solvent can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9
Part, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts.
It is understood that bath gel composition is in addition to can being above-mentioned cited a kind of performance, also can use
Other well known in the art any type of bath gel.
Above-mentioned surfactant is as the main component of bath gel, and it plays the effect that decontamination is deoiled.Surfactant can
List sodium laureth sulfate and/or coconut oleoyl amine DEA.Except this, can be also with alkenyl sulphonate, N-glutamatic acid and
Its salt, sulfosuccinate, the Sulfonates anion surfactant of isethionic acid ester, with N-Laurel phthalein sodium sarcosinate,
N-lauric acid sarcosine ammonium, N-Cortex cocois radicis phthalein sodium sarcosinate, N-lima bean model phthalein sodium sarcosinate are that the N-phthalein sarcosine salt of representative is cloudy
Ionic surface active agent, with glycine betaine and its derivant, both sexes sodium acetate, alkylol phthalein amine salt, fatty alcohol phthalein amine salt as generation
The amphoteric surfactant of table.
Emollient plays the effect of the moisturizing to skin.The example of glycerol and/or Palmic acid can be listed, can be also PEG-
7 glyceryl cocoates.
The effect of viscosity-controlling agent is the regulation playing viscosity.The example of sodium chloride can be listed, can also be poly-certainly
Ethylene glycol bis tristearin vinegar, acrylate copolymer, the general derivant of glucose, cellulose derivative or inorganic salt.
The effect of pigment is the regulation playing color.Can list pigment is the concrete real of CI17200 and/or CI42090
Example.Here, No. CAS of CI17200 is 3567-66-6.CI42090 is sapphirine or cyan one.
The effect of preservative is the effect playing sterilization.Methylchloroisothiazandnone and/or methyl-isothiazol can be listed
Quinoline ketone.
Solvent can list 1, and 2-pentanediol, can also be other certainly, such as propylene glycol etc.,
Bath gel component, in addition to above-mentioned, also can comprise freshener.The effect of freshener is to play refrigerant effect, can arrange
Enumerate Borneolum Syntheticum, Folium Menthae extract, menthol etc..
The content of freshener, according to mass parts, is advisable with 5～10 parts, such as 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5
Part, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10 parts.
The bath gel of the present invention, in addition to mentioned component, also can comprise, according to mass parts, and 5～10 parts of pentetic acid, specifically
Ground, its mass parts can be 5 parts, 5.2 parts, 5.5 parts, 6 parts, 7 parts, 7.5 parts, 8 parts, 9 parts, 9.5 parts, 9.8 parts, 9.9 parts or 10
Part etc..Pentetic acid has another name called Calcium Chel 330, and its No. CAS is 67-43-6.The effect of pentetic acid is, can network direct with radionuclide
Cooperation use, is discharged through kidney by expectoration or absorb in blood again, effectively removes the radionuclide of deposition, including lanthanum, cerium,
Praseodymiums etc., lung sucks Pentetate inhalant simultaneously, it is also possible to by absorbing in blood, occurs with the radionuclide in blood
Complexing, discharges through kidney, effectively removes whole body and pollutes.
The Main Function of cocoa extract is a kind of fat-reducing factor, because it contains theobromine and caffeine, it is a kind of
Slimming ingredient.The composition of cocoa extract contain polyphenol, xanthine, cocoa butter (such as lipid and phospholipid, and single glyceride and
Two glyceride).Cocoa extract also can make skin benefits, such as, refer to the one or more required effects on skin, bag
Include the overall improvement to skin health.Skin benefits includes following one or more: the robustness of increase, the bullet of increase
Property, the tension force of increase, the wrinkle (including wrinkle width and/or volume) of minimizing, reduce fine rule, the hydration of increase, fall
Low skin coarseness, the decortication of reduction, the skin texture (including skin barrier) of improvement.Another skin benefits for taking off (or
Desalination) senile plaque.Preferably, skin benefits does not include skin erythema and/or the photoaging reducing uv induction.Skin benefits is excellent
It is selected in facial skin, body skin or both upper acquisitions.
The preparation method of the bath gel of the present invention, is to be mixed by each raw material, as mixing mode and mixing time
Between wait technological parameter to be reached uniformly for for the purpose of uniform by mixing.It addition, the charging sequence to each raw material in Hun He, permissible
Select according to actual, no longer describe in detail in this.
Embodiment 1
First each raw material of proportioning, is specially (according to mass parts): 5 parts of green tea extracts, 5.2 parts of Fructus Crataegi extracts, 5.2 parts
Herb Gynostemmae Pentaphylli extract, 5.5 portions of Folium Nelumbinis extracts, 5.1 portions of Folium Sennae extracts, 5.2 portions of Semen Cassiae extracts, 5.05 portions of Fructus Luffaes carry
Take thing, 5 parts of citric acids, 5 parts of lavender flower extracts, 5 parts of essence, 5 parts of sodium chlorides, 5 parts of sodium laureth sulfate, 5 parts
Coconut oleoyl amine, 5 parts of 1.2-pentanediols, 5 parts of glycerol, 5 parts of methylchloroisothiazandnone, 5 parts of Methylisothiazolinone, 5 parts
CI17200,5 parts of CI42090,5 parts of Palmic acids, 5 parts of pentetic acid, 5 parts of Borneolum Syntheticums, 5 parts of cocoa extracts.
Blend step.I.e. particularly as follows: first green tea, Fructus Crataegi, Herb Gynostemmae Pentaphylli, cocoa Chinese medicine ingredients extract are put in agitator
It is stirred.Again Folium Nelumbinis, Folium Sennae, Semen Cassiae, lavender flower and Fructus Luffae extract are put in agitator and be stirred.And
After, pour citric acid, essence, sodium chloride, sodium laureth sulfate, the raw material of coconut oleoyl amine DEA chemical composition into appearance
Device is stirred.Then, the raw material of 1.2-pentanediol, glycerol, methylchloroisothiazandnone, Methylisothiazolinone is fallen
Enter in container and be stirred.CI17200, CI42090, Palmic acid, pentetic acid, the raw material of Borneolum Syntheticum are poured in container and stirred
Mix.
Finally, use advanced automated production equipment, pack at last joint sealing, by manual operation.
Embodiment 2
First each raw material of proportioning, is specially (according to mass parts): 10 parts of green tea extracts, 9.8 parts of Fructus Crataegi extracts, 9.5
Part Herb Gynostemmae Pentaphylli extract, 9.8 portions of Folium Nelumbinis extracts, 9.7 portions of Folium Sennae extracts, 9.7 portions of Semen Cassiae extracts, 9.6 portions of Fructus Luffaes
Extract, 10 parts of citric acids, 10 parts of lavender flower extracts, 10 parts of essence, 10 parts of sodium chlorides, 10 parts of laureth sulfuric esters
Sodium, 10 parts of coconut oleoyl amines, 10 parts of 1.2-pentanediols, 10 parts of glycerol, 10 parts of methylchloroisothiazandnone, 10 parts of methylisothiozoline
Ketone, 10 parts of CI17200,10 parts of CI42090,10 parts of Palmic acids, 10 parts of pentetic acid, 10 parts of Borneolum Syntheticums, 10 parts of cocoa extracts.
Blend step.I.e. particularly as follows: first green tea, Fructus Crataegi, Herb Gynostemmae Pentaphylli, cocoa Chinese medicine ingredients extract are put in agitator
It is stirred.Again Folium Nelumbinis, Folium Sennae, Semen Cassiae, lavender flower and Fructus Luffae extract are put in agitator and be stirred.And
After, pour citric acid, essence, sodium chloride, sodium laureth sulfate, the raw material of coconut oleoyl amine DEA chemical composition into appearance
Device is stirred.Then, the raw material of 1.2-pentanediol, glycerol, methylchloroisothiazandnone, Methylisothiazolinone is fallen
Enter in container and be stirred.CI17200, CI42090, Palmic acid, pentetic acid, the raw material of Borneolum Syntheticum are poured in container and stirred
Mix.
Finally, use advanced automated production equipment, pack at last joint sealing, by manual operation.
Embodiment 3
First each raw material of proportioning, is specially (according to mass parts): 7.5 parts of green tea extracts, 7.2 parts of Fructus Crataegi extracts, 7.8
Part Herb Gynostemmae Pentaphylli extract, 8 portions of Folium Nelumbinis extracts, 7.6 portions of Folium Sennae extracts, 7.4 portions of Semen Cassiae extracts, 7.5 portions of Fructus Luffaes carry
Take thing, 7.5 parts of citric acids, 7.6 parts of lavender flower extracts, 7.5 parts of essence, 7.5 parts of sodium chlorides, 7.5 parts of laureth sulfur
Acid esters sodium, 7.5 parts of coconut oleoyl amines, 7.5 parts of 1.2-pentanediols, 7.5 parts of glycerol, 7.5 parts of methylchloroisothiazandnone, 7.5 parts of first
Base isothiazolone, 7.5 parts of CI17200,7.5 parts of CI42090,7.5 parts of Palmic acids, 7.5 parts of pentetic acid, 7.5 parts of Borneolum Syntheticums, 7.2
Part cocoa extract.
Blend step.I.e. particularly as follows: first green tea, Fructus Crataegi, Herb Gynostemmae Pentaphylli, cocoa Chinese medicine ingredients extract are put in agitator
It is stirred.Again Folium Nelumbinis, Folium Sennae, Semen Cassiae, lavender flower and Fructus Luffae extract are put in agitator and be stirred.And
After, pour citric acid, essence, sodium chloride, sodium laureth sulfate, the raw material of coconut oleoyl amine DEA chemical composition into appearance
Device is stirred.Then, the raw material of 1.2-pentanediol, glycerol, methylchloroisothiazandnone, Methylisothiazolinone is fallen
Enter in container and be stirred.CI17200, CI42090, Palmic acid, pentetic acid, the raw material of Borneolum Syntheticum are poured in container and stirred
Mix.
Finally, use advanced automated production equipment, pack at last joint sealing, by manual operation.
Embodiment 4
First each raw material of proportioning, is specially (according to mass parts): 8 parts of green tea extracts, 7.6 parts of Fructus Crataegi extracts, 7.2 parts
Herb Gynostemmae Pentaphylli extract, 7.5 portions of Folium Nelumbinis extracts, 7.5 portions of Folium Sennae extracts, 7.5 portions of Semen Cassiae extracts, 7.5 portions of Fructus Luffaes carry
Take thing, 7 parts of citric acids, 7.5 parts of lavender flower extracts, 7.5 parts of essence, 7.5 parts of sodium chlorides, 7.5 parts of laureth sulphuric acid
Ester sodium, 7.5 parts of coconut oleoyl amines, 7.5 parts of 1.2-pentanediols, 7.5 parts of glycerol, 7.5 parts of methylchloroisothiazandnone, 7.5 parts of methyl
Isothiazolone, 7.5 parts of CI17200,7.5 parts of CI42090,7.5 parts of Palmic acids, 5～10 parts of pentetic acid, 7.5 parts of Borneolum Syntheticums, 7.2
Part cocoa extract.
Blend step.I.e. particularly as follows: first green tea, Fructus Crataegi, Herb Gynostemmae Pentaphylli, cocoa Chinese medicine ingredients extract are put in agitator
It is stirred.Again Folium Nelumbinis, Folium Sennae, Semen Cassiae, lavender flower and Fructus Luffae extract are put in agitator and be stirred.And
After, pour citric acid, essence, sodium chloride, sodium laureth sulfate, the raw material of coconut oleoyl amine DEA chemical composition into appearance
Device is stirred.Then, the raw material of 1.2-pentanediol, glycerol, methylchloroisothiazandnone, Methylisothiazolinone is fallen
Enter in container and be stirred.CI17200, CI42090, Palmic acid, pentetic acid, the raw material of Borneolum Syntheticum are poured in container and stirred
Mix.
Finally, use advanced automated production equipment, pack at last joint sealing, by manual operation.
The present invention uses traditional theory of Chinese medical science, in conjunction with the living habit of people, conveniently, freely, for everybody fat personage
Successful weight loss.Test through numerous experimenters, within a week, obvious fat-reducing effect, about fat-reducing 3-6 jin can be received.
Owing to the numerical range of each technological parameter involved in the present invention can not all embody in the above-described embodiments,
As long as but the most envisioned any numerical value fallen in this numerical range above-mentioned of those skilled in the art all can implement this
Invention, the most also includes the combination in any of occurrence in the range of some numerical value.Herein, for the consideration of length, eliminate to
Going out the embodiment of occurrence in certain one or more numerical range, this disclosure being not to be construed as technical scheme is not filled
Point.
Applicant states, the present invention illustrates detailed process equipment and the technological process of the present invention by above-described embodiment,
But the invention is not limited in above-mentioned detailed process equipment and technological process, i.e. do not mean that the present invention have to rely on above-mentioned in detail
Process equipment and technological process could be implemented.Person of ordinary skill in the field it will be clearly understood that any improvement in the present invention,
The equivalence of raw material each to product of the present invention is replaced and the interpolation of auxiliary element, concrete mode selection etc., falls in the protection of the present invention
In the range of.
Claims (10)
1. a bath gel with effect of weight reducing, it is characterised in that comprise 5～10 portions of green tea according to its raw material of mass parts and extract
Thing, 5～10 portions of Fructus Crataegi extracts, 5～10 portions of Herb Gynostemmae Pentaphylli extracts, 5～10 portions of Folium Nelumbinis extracts, 5～10 portions of Folium Sennae extract
Thing, 5～10 parts of Semen Cassiae extracts, 5～10 parts of Fructus Luffae extracts, 5～10 parts of citric acids, 5～10 parts of lavender flower extracts,
And bath gel component.
Bath gel the most according to claim 1, it is characterised in that comprise 10～20 according to bath gel component described in mass parts
Part surfactant, 10～20 parts of emollient, 5～10 parts of viscosity-controlling agents, 10～20 parts of pigments, 10～20 portions of preservative, 5～
10 parts of essence and 5～10 parts of solvents.
Bath gel the most according to claim 2, it is characterised in that described surfactant is sodium laureth sulfate
And/or coconut oleoyl amine DEA.
Bath gel the most according to claim 2, it is characterised in that described emollient is glycerol and/or Palmic acid.
Bath gel the most according to claim 2, it is characterised in that described pigment is CI17200 and/or CI42090.
Bath gel the most according to claim 2, it is characterised in that described preservative be methylchloroisothiazandnone and/or
Methylisothiazolinone.
Bath gel the most according to claim 2, it is characterised in that according to bath gel component described in mass parts also comprise 5～
10 portions of fresheners.
Bath gel the most according to claim 1, it is characterised in that also comprise 5～10 parts of pentetic acid according to mass parts.
Bath gel the most according to claim 1, it is characterised in that also comprise 5～10 parts of cocoa extracts according to mass parts.
10. the preparation method of a bath gel as claimed in claim 1, it is characterised in that obtained by each raw material mix homogeneously.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610573423.1A CN106176350A (en) | 2016-07-20 | 2016-07-20 | Bath gel with effect of weight reducing and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610573423.1A CN106176350A (en) | 2016-07-20 | 2016-07-20 | Bath gel with effect of weight reducing and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106176350A true CN106176350A (en) | 2016-12-07 |
Family
ID=57493632
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610573423.1A Pending CN106176350A (en) | 2016-07-20 | 2016-07-20 | Bath gel with effect of weight reducing and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106176350A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109793698A (en) * | 2019-03-29 | 2019-05-24 | 广州欧舒丹生物科技有限公司 | A kind of bath foam and preparation method thereof with weight losing function |
| CN110917049A (en) * | 2019-10-29 | 2020-03-27 | 罗晋山 | Fullerene-containing Chinese herbal medicine formula capable of preventing obesity and resisting aging |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101536970A (en) * | 2009-01-16 | 2009-09-23 | 陈明慧 | Shower gel with weight reducing function |
| CN102113984A (en) * | 2011-02-25 | 2011-07-06 | 广州市天吻娇颜化妆品有限公司 | Composite with function of reducing weight of abdomen |
| CN104042684A (en) * | 2013-11-28 | 2014-09-17 | 天津天狮生物发展有限公司 | Traditional Chinese medicinal composition containing Gynostemma pentaphylla extract, and preparation method thereof |
-
2016
- 2016-07-20 CN CN201610573423.1A patent/CN106176350A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101536970A (en) * | 2009-01-16 | 2009-09-23 | 陈明慧 | Shower gel with weight reducing function |
| CN102113984A (en) * | 2011-02-25 | 2011-07-06 | 广州市天吻娇颜化妆品有限公司 | Composite with function of reducing weight of abdomen |
| CN104042684A (en) * | 2013-11-28 | 2014-09-17 | 天津天狮生物发展有限公司 | Traditional Chinese medicinal composition containing Gynostemma pentaphylla extract, and preparation method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 王建新等: "《化妆品植物原料大全》", 30 June 2012 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109793698A (en) * | 2019-03-29 | 2019-05-24 | 广州欧舒丹生物科技有限公司 | A kind of bath foam and preparation method thereof with weight losing function |
| CN110917049A (en) * | 2019-10-29 | 2020-03-27 | 罗晋山 | Fullerene-containing Chinese herbal medicine formula capable of preventing obesity and resisting aging |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6077554B2 (en) | Wrapping fermentation method using medicinal flowers and skin external preparation composition using the method | |
| CN104825351B (en) | A kind of Lignum Aquilariae Resinatum whitening cleansing facial milk containing and preparation method thereof | |
| CN105327336A (en) | Chinese herbal medicine containing herba catharanthi rosei, aloes, radix zanthoxyli and mint, skin absorbable lotion and diet therapy | |
| CN104606106A (en) | Natural plant nano-emulsion bath lotion | |
| JP2005501851A (en) | Composition for removing toxins | |
| KR101284656B1 (en) | Cosmetic Composition | |
| CN102258453B (en) | Natural hair and skin beautifying nursing agent and using method thereof | |
| CN105125466A (en) | Freckle removing night cream and preparing method thereof | |
| KR100564108B1 (en) | Cosmetic composition comprising plant extract having anti-aging effect | |
| KR100873033B1 (en) | Cosmetic composition for massage pack | |
| CN104116672A (en) | Compound natural facial mask and preparation method thereof | |
| CN106176350A (en) | Bath gel with effect of weight reducing and preparation method thereof | |
| CN108853356A (en) | A kind of man is delayed spray and preparation method thereof | |
| CN112656930A (en) | Traditional Chinese medicine shampoo for growing and blackening hair and preparation method thereof | |
| CN104644535A (en) | Hair and body wash powder | |
| CN107375087A (en) | A kind of shower cream and preparation method thereof | |
| CN106913492A (en) | A kind of antibacterial antioxidant composition of wormwood and its application in shampoo | |
| CN105796409A (en) | Bath salt and preparation method thereof | |
| CN104414954A (en) | Snail skin cream for relieving allergy | |
| CN103484272A (en) | Chinese herb medicinal soap | |
| CN106333918A (en) | After-sun repair attapulgite face cream | |
| CN105441230A (en) | Camellia oil cold processed soap | |
| KR101685686B1 (en) | Scrub Cosmetic Composition Comprising Solar Salt | |
| CN107779320A (en) | A kind of green peel of walnut clean skin product and preparation method thereof | |
| CN105106085A (en) | Chinese medicinal herb sunscreen cream containing attapulgite |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |
|
| RJ01 | Rejection of invention patent application after publication |